Bartl, T.; Karacs, J.; Kreuzinger, C.; Pfaffinger, S.; Kendler, J.; Ciocsirescu, C.; Wolf, A.; Reinthaller, A.; Meyer, E.; Brandstetter, M.;
et al. Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients. Cancers 2021, 13, 1076.
https://doi.org/10.3390/cancers13051076
AMA Style
Bartl T, Karacs J, Kreuzinger C, Pfaffinger S, Kendler J, Ciocsirescu C, Wolf A, Reinthaller A, Meyer E, Brandstetter M,
et al. Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients. Cancers. 2021; 13(5):1076.
https://doi.org/10.3390/cancers13051076
Chicago/Turabian Style
Bartl, Thomas, Jasmine Karacs, Caroline Kreuzinger, Stephanie Pfaffinger, Jonatan Kendler, Cristina Ciocsirescu, Andrea Wolf, Alexander Reinthaller, Elias Meyer, Maximilian Brandstetter,
and et al. 2021. "Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients" Cancers 13, no. 5: 1076.
https://doi.org/10.3390/cancers13051076
APA Style
Bartl, T., Karacs, J., Kreuzinger, C., Pfaffinger, S., Kendler, J., Ciocsirescu, C., Wolf, A., Reinthaller, A., Meyer, E., Brandstetter, M., Postl, M., Langthaler, E., Braicu, E., Vergote, I., Cunnea, P., Gourley, C., Schmitt, W. D., Cacsire Castillo-Tong, D., & Grimm, C.
(2021). Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients. Cancers, 13(5), 1076.
https://doi.org/10.3390/cancers13051076